Chronic Kidney Disease Risk Reduction in a Hispanic Population Through Pharmacist-Based Disease-State Management

Advances in Chronic Kidney Disease

Volumn 15, Issue 2, 2008, Pages 162-167

  Leal, Sandra ^a   Soto, Marisa ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Chronic kidney disease; Community health center; Hispanic; Pharmacist collaborative practice; Pharmacist based disease state management

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CERTIFICATION; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMMUNITY PROGRAM; COMORBIDITY; DIABETES EDUCATION; DIABETES MELLITUS; FEMALE; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HISPANIC; HUMAN; INDIGENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RISK REDUCTION; SOCIOECONOMICS; UNITED STATES;

ADULT; AGED; ARIZONA; COMMUNITY HEALTH CENTERS; COMMUNITY PHARMACY SERVICES; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PATIENT CARE TEAM; PHARMACISTS; PROGRAM EVALUATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 40249088223     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2008.01.007     Document Type: Article

References (35)

1. Intermountain End-Stage Renal Disease Network, Inc: ESRD Network Organization #15: Annual Report 2006. Centers for Medicare & Medicaid Services January 1, 2006-December 31, 2006
2. American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26 (2003) 917-932
3. Saaddine J.B., Engelgau M.M., Beckles G.L., et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 136 (2002) 565-574
4. Maljanian R., Grey N., Staff I., et al. Improved diabetes control through a provider-based disease management program. Dis Manage Health Outcomes 10 (2002) 1-8
5. Norris S.L., Nichols P.J., Casperson C.J., et al. The effectiveness of disease and case management for people with diabetes: A systemic review. Am J Prev Med 22 (2002) 15-38
6. Bessman A.N. Comparison of medical care in nurse clinician and physician clinics in medical school affiliated hospitals. J Chronic Dis 27 (1974) 115-125
7. Stein G.H. The use of a nurse practitioner in the management of patients with diabetes mellitus. Med Care 12 (1974) 885-890
8. Coast-Senior E.A., Kroner B.A., Kelley C.L., et al. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 32 (1998) 636-640
9. American Diabetes Association: National Diabetes Fact Sheet (2003), ADA, Alexandria, VA
10. Hogan P., Dall T., and Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
11. Anderson P.O., and Taryle D.A. Pharmacist management of ambulatory patients using formalized standards of care. Am J Hosp Pharm 31 (1974) 254-257
12. Johnson R.E., and Tuchler R.J. Role of the pharmacist in primary health care. Am J Hosp Pharm 32 (1975) 162-164
13. Erickson S.H. Primary care by a pharmacist in an outpatient clinic. Am J Hosp Pharm 34 (1977) 1086-1090
14. Copeland G.P., and Apgar D.A. The pharmacist practitioner training program. Drug Intell Clin Pharm 14 (1980) 114-119
15. Church R.M. Pharmacy practice in the Indian health service. Am J Hosp Pharm 44 (1987) 771-775
16. Herrier R.N., Boyce R.W., and Apgar D.A. Pharmacist-managed patient care services and prescriptive authority in the U.S. Public Health Service. Hosp Formul 25 (1990) 67-68 76-78, 80
17. Solomon D.K., Portner T.S., Bass G.E., et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 38 (1998) 574-585
18. Okamoto M.P., and Nakahiro R.K. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 21 (2001) 1337-1344
19. Bluml B.M., McKenney J.M., and Cziraky M.J. Pharmaceutical care services and results in project impact: hyperlipidemia. J Am Pharm Assoc 40 (2000) 157-165
20. Whellan D.J., Gaulden L., Gattis W.A., et al. The benefit of implementing a heart failure disease management program. Arch Intern Med 161 (2001) 2223-2228
21. Chiquette E., Amato M.G., and Bussey H.I. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes and health care costs. Arch Int. Med 158 (1998) 1641-1647
22. Cordina M., McElnay J.C., and Hughes C.M. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy 21 (2002) 1196-1203
23. Kelley C., and Rodgers P.T. Implementation and evaluation of a pharmacist-managed diabetes service. J Manage Care Pharm 6 (2000) 488-493
24. Nau D.P., Blevins J.D., and Neal S.E. Collaborating with community pharmacists to improve the quality of diabetes care in an IPA model HMO. J Manage Care Pharm 7 (2001) 292-296
25. Anon. Collaborative drug therapy agreements lead to improved diabetes management. Formulary 36 (2001) 538-539
26. Yanchick J.K. Implementation of drug therapy monitoring clinic in a primary care setting. Am J Health Syst Pharm 57 suppl 4 (2000) S30-S37
27. Baran R.W., Crumlish K., Patterson H., et al. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health Syst Pharm 56 (1999) 1535-1539
28. Nau D.P., and Ponte C.D. Effects of community pharmacy-based diabetes patient-management program on intermediate clinical outcome measures. J Manag Care Pharm 8 (2002) 48-53
29. Cranor C.W., and Christensen D.B. The Ashville project: Short-term outcomes of a community pharmacy-based diabetes care program. J Am Pharm Assoc 43 (2003) 149-159
30. Kelley C., and Rodgers P.T. Implementation and evaluation of a pharmacist-managed diabetes service. J Manag Care Pharm 6 (2000) 488-493
31. Shane-McWhorter L., and Oderda G.M. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy 25 (2005) 96-109
32. Knapp K.K., Okamota M.P., and Black B.L. ASHP survey of ambulatory care pharmacy practice in health systems: 2004. Am J Health Syst Pharm 62 (2005) 274-284
33. Leal S., Herrier R.N., Glover J.J., and Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care 27 (2004) 2983-2984
34. Leichter S.B., Faulkner S., and Camp J. On the cost of being a diabetic patient: variables for physician prescribing behavior. Clin Diabetes 18 (2000) 42-44
35. Insuring America's Health: Principles and Recommendations. Committee on the Consequences of Uninsurance (2004), Board on Health Care Services, Institute of Medicine, Washington, DC pp 1-160